Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Thoppil

Obstetrics & Gynecology Austin, TX Medical Doctor

NPI 1336138064 CMS profile 571669

6611 River Place Blvd, Suite 202, Austin, TX 78730

Open in the dashboard

General payments

$25,140

313 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$5

5 holdings reported · through program year 2025

Through program year 2025, John Thoppil of Austin, TX is reported in the CMS Open Payments database as having received $25,140 across 313 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $5 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,078 34
2024 General $1,234 34
2023 General $15,414 48
2022 General $2,469 51
2021 General $1,180 49
2020 General $2,161 48
2019 General $1,605 49
2024 Ownership $1 1
2023 Ownership $1 1
2022 Ownership $1 1
2021 Ownership $1 1
2020 Ownership $1 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Thoppil
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to John Thoppil were reported at $1,078. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year John Thoppil Obstetrics & Gynecology median Middle half National median
2019 $1,605 $172 $62–$391 $163
2020 $2,161 $94 $36–$222 $114
2021 $1,180 $136 $42–$369 $132
2022 $2,469 $160 $50–$433 $149
2023 $15,414 $169 $56–$423 $160
2024 $1,234 $152 $50–$371 $164
2025 $1,078 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Exeltis, USA Inc. $14,451 31 payments
  2. TherapeuticsMD, Inc. $2,025 41 payments
  3. Shield Therapeutics Inc $1,712 8 payments
  4. AbbVie, Inc. $994 36 payments
  5. Hologic, LLC $853 15 payments
  6. Davol Inc. $640 7 payments
  7. Mayne Pharma Inc. $549 22 payments
  8. Astellas Pharma US Inc $392 11 payments
  9. Evofem Biosciences, Inc. $372 16 payments
  10. DySIS Medical, Inc. $362 4 payments
  11. Other $2,790 122 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $15,200 2 payments
  2. Food and Beverage $8,360 309 payments
  3. Honoraria $1,500 1 payment
  4. Education $80 1 payment
Products named General payments · program years 2019–2025
  1. SLYND $14,105 11 payments
  2. ACCRUFER $1,712 8 payments
  3. ANNOVERA $1,319 11 payments
  4. Phasix Mesh $425 5 payments
  5. Kyleena $327 18 payments
  6. Orilissa $309 10 payments
  7. Veozah $299 9 payments
  8. Mirena $299 16 payments
  9. IMVEXXY $275 14 payments
  10. ACESSA PROVU SYSTEM $274 4 payments
  11. Other $6,322 241 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$4,442

Medicare's payments for the services billed

Medicare patients

19

Average age 69

Services billed

43

19 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Chronic kidney disease 0%
COPD 0%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 6 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ULTOMIRIS
  • Alexion Pharmaceuticals, Inc. $85
$85 — —
SLYND
  • Exeltis, USA Inc. $84
$84 — —
ABRYSVO
  • PFIZER INC. $51
$51 — —
Veozah
  • Astellas Pharma US Inc $49
$49 — —
ZEPBOUND
  • Lilly USA, LLC $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 6 in the dashboard with a free account

Records

313 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record